Your browser doesn't support javascript.
loading
Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada.
Russell, Cayley; Pang, Michelle; Nafeh, Frishta; Farrell Macdonald, Shanna; Derkzen, Dena; Rehm, Jürgen; Fischer, Benedikt.
Afiliação
  • Russell C; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Pang M; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Nafeh F; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Farrell Macdonald S; Policy Sector, Research Branch, Correctional Service of Canada, Ottawa, Ontario, Canada.
  • Derkzen D; Policy Sector, Research Branch, Correctional Service of Canada, Ottawa, Ontario, Canada.
  • Rehm J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
  • Fischer B; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Int J Qual Stud Health Well-being ; 17(1): 2094111, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35787743
INTRODUCTION: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada. METHODS: This article describes results from a longitudinal mixed-methods study examining OAT transition experiences among thirty-five individuals released from federal incarceration in Ontario, Canada. Assessments were completed within one year of participants' release. Data were thematically analyzed. RESULTS: The majority (77%) of participants remained engaged in OAT, however, 69% had their release suspended and 49% returned to custody. Key facilitators for OAT engagement included flexibility, positive staff rapport, and structure. Fragmented OAT transitions, financial OAT coverage, balancing reintegration requirements, logistical challenges, and inaccessibility of 'take-home' OAT medications were common barriers. CONCLUSIONS: Post-incarceration transition periods are critical for OAT retention, yet individuals in Ontario experience barriers to OAT engagement that contribute to treatment disruptions and related risks such as relapse and/or re-incarceration. Additional measures to support community OAT transitions are required, including improved discharge planning, amendments to OAT and financial coverage policies, and an expansion of OAT options.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento de Substituição de Opiáceos / Analgésicos Opioides Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Int J Qual Stud Health Well-being Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento de Substituição de Opiáceos / Analgésicos Opioides Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Int J Qual Stud Health Well-being Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá